Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
St. Jude Children’s Research Hospital scientists report that avian H2N2 influenza A viruses related to 1957-1958 pandemic infect human cells and spread among ferrets; may aid identification of emerging threats. (Dr. Robert Webster)
St. Jude Children’s Research Hospital scientists warn the flu virus that caused a pandemic in the 1950s remains a threat today. The risk is greatest for those under age 50; this group lacks immunity to the virus.
Virologist Robert G. Webster, Ph.D., of St. Jude Children’s Research Hospital, is the recipient of the Charles Mérieux Award from the National Foundation for Infectious Diseases (NFID).
Renowned virologist Robert Webster, Ph.D., was invited to give the 2010 Leeuwenhoek Lecture by the Royal Society in London. The Leeuwenhoek Lecture, named after microscopist Antony van Leeuwenhoek, was established to recognize excellence in the field of microbiology.
Acclaimed virologist Robert Webster, Ph.D., of St. Jude Children’s Research Hospital, presented the 2010 Leeuwenhoek prize lecture today, a prestigious recognition awarded by the Royal Society in London.
Robert Webster, PhD, is recognized by the world’s oldest scientific academy for his contributions to the field of virology.
St. Jude researchers have discovered a key factor of fatal influenza virus infection that suggests a possible new way to treat the disease and to greatly reduce the death toll of a potential worldwide pandemic like the 1918 Spanish flu.
The cytokine storm is a blizzard of signaling proteins that is generated by various immune system cells as they coordinate an attack on an invading microorganism. If this response runs out of control, it can cause potentially fatal inflammation and damage to the lungs. It has been thought that this is what kills people who are infected with H5N1.
A new wave of H5N1 transmission through Asia despite containment measures highlights the need for more information on the movement of the virus into and out of southern China.
St. Jude vaccine offers cross-protection in ferrets against different variants of H5N1, suggesting it could be stockpiled for use in the event of a human outbreak.
Scientists at St. Jude Children's Research Hospital have announced that a vaccine they developed a few years ago against one antigenic variant of the avian influenza virus H5N1 may protect humans against future variants of the virus.
The H5N1 avian influenza virus continues to spread from its original source in southern China through transported poultry and bird migration. The virus has now established distinct subpopulations throughout Asia.
Robert G. Webster, Ph.D., who holds the Rose Marie Thomas Chair at St. Jude, has been given the Distinguished Biotechnologist of the Year Award by the New Zealand Biotechnology Association for his work in virology and avian influenza.
Unique resources at St. Jude Children's Research Hospital let researchers generate a "gold mine" of data to track evolution of bird flu virus genes and understand how they cooperate to cause disease.
Robert G. Webster, PhD, who holds the Rose Marie Thomas Chair at St. Jude Children's Research Hospital, has been named by Scientific American magazine as a "Research Leader" within the 2005 Scientific American 50...
Resistance to the antiviral drug amantadine is spreading significantly more rapidly among avian influenza viruses of H5N1 subtype in Southeast Asia than in North America.
Robert Webster, PhD, world-renowned flu expert and professor of virology uses his St. Jude laboratory to track emerging new flu viruses and guide the development of flu vaccines to stop them.
An avian influenza virus that has caused three major outbreaks among poultry and killed several people in East Asia over the past seven years arose through a series of genetic reassortment events with other viruses.
Robert Webster, PhD, world-renowned virologist at St. Jude Children's Research Hospital, has been interviewed about the threat of infectious diseases by top news organizations around the country.
Scientists at St. Jude Children's Research Hospital announced today the development of a vaccine against H5N1, a new lethal influenza virus that triggered the World Health Organization (WHO) to declare a pandemic alert in February 2003.